compared to its average ratio and a 36-month beta value of -0.46. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NVOS is 144.38M, and currently, short sellers hold a 3.44% ratio of that float. The average trading volume of NVOS on September 19, 2023 was 43.35M shares.
NVOS) stock’s latest price update
The stock of Novo Integrated Sciences Inc. (NASDAQ: NVOS) has decreased by -15.00 when compared to last closing price of 0.40. Despite this, the company has experienced a -7.10% fall in its stock price over the last five trading sessions. PennyStocks reported 2023-09-13 that Let’s be honest – penny stocks priced at less than a buck hold an irresistible appeal. Even a small investment could potentially lead to insane returns.
NVOS’s Market Performance
Novo Integrated Sciences Inc. (NVOS) has seen a -7.10% fall in stock performance for the week, with a 122.95% gain in the past month and a 136.28% surge in the past quarter. The volatility ratio for the week is 32.86%, and the volatility levels for the past 30 days are at 30.86% for NVOS. The simple moving average for the past 20 days is 36.19% for NVOS’s stock, with a 121.47% simple moving average for the past 200 days.
NVOS Trading at 101.19% from the 50-Day Moving Average
After a stumble in the market that brought NVOS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.80% of loss for the given period.
Volatility was left at 30.86%, however, over the last 30 days, the volatility rate increased by 32.86%, as shares surge +155.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +150.37% upper at present.
During the last 5 trading sessions, NVOS fell by -7.10%, which changed the moving average for the period of 200-days by +38.78% in comparison to the 20-day moving average, which settled at $0.2600. In addition, Novo Integrated Sciences Inc. saw 69.07% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NVOS
Current profitability levels for the company are sitting at:
- -81.67 for the present operating margin
- +17.92 for the gross margin
The net margin for Novo Integrated Sciences Inc. stands at -279.86. The total capital return value is set at -20.61, while invested capital returns managed to touch -84.59.
Based on Novo Integrated Sciences Inc. (NVOS), the company’s capital structure generated 60.41 points at debt to equity in total, while total debt to capital is 37.66. Total debt to assets is 32.97, with long-term debt to equity ratio resting at 14.82. Finally, the long-term debt to capital ratio is 9.24.
When we switch over and look at the enterprise to sales, we see a ratio of 6.33, with the company’s debt to enterprise value settled at 0.23. The receivables turnover for the company is 5.35 and the total asset turnover is 0.23. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.41.
To put it simply, Novo Integrated Sciences Inc. (NVOS) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.